Paper · 39337476
The Furin Protease Dependence and Antiviral GBP2 Sensitivity of Murine Leukemia Virus Infection Are Determined by the Amino Acid Sequence at the Envelope Glycoprotein Cleavage Site.
Kubo Y and 3 others. Int J Mol Sci, 2024. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Furin Protease Dependence and Antiviral GBP2 Sensitivity of Murine Leukemia Virus Infection Are Determined by the Amino Acid Sequence at the Envelope Glycoprotein Cleavage Site. Papers, record 39337476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337476
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Furin Protease Dependence and Antiviral GBP2 Sensitivity of Murine Leukemia Virus Infection Are Determined by the Amino Acid Sequence at the Envelope Glycoprotein Cleavage Site.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Furin | Major topic |
| Viral Envelope Proteins | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Amino Acid Sequence | |
| Leukemia Virus, Murine | |
| Retroviridae Infections | |
| Virus Replication | |
| GTP-Binding Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 19K07593 | Japan Society for the Promotion of Science | PubMed | ||
| 22K08581 | Japan Society for the Promotion of Science | PubMed | ||
| no number | Asahi Kasei Medical Co., LTD | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33,472,929 | Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus. | J Virol | 2021 | https://conductscience.org/library/papers/33472929 | PubMed |
| 2 | 2,842,430 | CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). | J Exp Med | 1988 | https://conductscience.org/library/papers/2842430 | PubMed |
| 3 | 34,578,445 | Patterns of Coevolutionary Adaptations across Time and Space in Mouse Gammaretroviruses and Three Restrictive Host Factors. | Viruses | 2021 | https://conductscience.org/library/papers/34578445 | PubMed |
| 4 | 9,990,033 | A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/9990033 | PubMed |
| 5 | 24,711,391 | Furin cleavage of the Moloney murine leukemia virus Env precursor reorganizes the spike structure. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24711391 | PubMed |
| 6 | 10,364,311 | Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction. | J Virol | 1999 | https://conductscience.org/library/papers/10364311 | PubMed |
| 7 | 28,418,930 | The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection. | Oncotarget | 2017 | https://conductscience.org/library/papers/28418930 | PubMed |
| 8 | 7,142,194 | Role of partial proteolysis in processing murine leukemia virus membrane envelope glycoproteins to the cell surface. A viral mutant with uncleaved glycoprotein. | J Biol Chem | 1982 | https://conductscience.org/library/papers/7142194 | PubMed |
| 9 | 37,958,732 | The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958732 | PubMed |
| 10 | 36,693,093 | SARS-CoV-2 evolution influences GBP and IFITM sensitivity. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36693093 | PubMed |
1 to 10 of 60
See all 60 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERVK-20 | 100,616,444 | PubTator's text mining | https://conductscience.org/library/genes/100616444 | NCBI Gene |
| FURIN | 5,045 | PubTator's text mining | https://conductscience.org/library/genes/5045 | NCBI Gene |
| GBP2 | 2,634 | PubTator's text mining | https://conductscience.org/library/genes/2634 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39337476
GET https://conductscience.org/api/papers/v1/39337476/references?page=2